27 Feb 2019
Non-viral delivery for gene therapy A next generation gene therapy delivery approach The Duchenne Research Fund committed £320,000 to accelerate research into alternative ways to deliver gene therapy to Duchenne patients, with the aim of increasing the number of...
7 Feb 2019
CRISPR for Duchenne Genome editing technology to correct the mutated dystrophin gene The Duchenne Research Fund awarded a £200,000 grant to the team at the Hospital for Sick Children in Toronto, Canada (‘Sick Kids’), to work on using CRISPR/Cas9 technology...
28 Feb 2017
KINEDMD study: developing an activity monitoring biomarker Using novel algorithms to chart daily activities of ambulant and non-ambulant boys The ground-breaking KineDMD project is a collaborative effort between Imperial College London, UCL and Great Ormond Street...